Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Smith Nephew ADR Representing 2 Ord Shs C.SNN


Primary Symbol: SNN

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.


NYSE:SNN - Post by User

Comment by NoMansGhoston Sep 27, 2018 5:25pm
174 Views
Post# 28704488

RE:Why the delay?

RE:Why the delay?My hunch based on the recent prospectus is that will not announce a shareholder's meeting to vote on the spin out until they have finalized exactly what they will be doing for the financing of the Canadian Campus. Once they have determined what they will be doing with the CAD assets of the company, I expect more information regarding the spin out to be revealed and everything to be set in motion. 

"Funding of the Sunniva Canada Campus is anticipated to be completed through a combination of debt, mezzanine and equity financing which the Company is continuing to pursue. The Company has also retained Canaccord to review all other strategic alternatives which may include a sale of, an investment in, or a joint venture for some or all of the Company’s Canadian assets. See “Use of Proceeds”.

- From Page 10 of the preliminary short form prospectus on 9/24/18  
<< Previous
Bullboard Posts
Next >>